Severe anemia during rituximab maintenance therapy for follicular lymphoma.
Sismanogleio Hospital, Athens, Greece.
Konstantinos
K
Liapis
Nikolaos
N
Harhalakis
George
G
Stefanou
John
J
Apostolidis
D000740:Anemia / Q000139:chemically induced*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab